— Know what they know.
Not Investment Advice
Also trades as: KERNW (NASDAQ) · $vol 0M

KERN NASDAQ

Akerna Corp.
1W: -3.5% 1M: -10.4% 3M: +20.1% 1Y: -67.3% 3Y: -99.8% 5Y: -99.8%
$0.31
Last traded 2024-02-08 — delisted
NASDAQ · Healthcare · Medical - Healthcare Information Services · $162320 mcap · 456425 float · 3.60% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$185K -99.1% ▼
Gross Profit
$93K -98.0% ▼
Operating Income
-$228K +98.7% ▲
Net Income
-$153K +99.3% ▲
EPS (Diluted)
$-0.00 +100.0% ▲
EBITDA
-$113K +99.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2021FY2022FY2024FY2025
Revenue$11M$21M$14M$21M$185K
YoY Growth+0.0%+0.0%-34.0%—-99.1%
Cost of Revenue$5M$8M$5M$16M$92K
Gross Profit$6M$13M$8M$5M$93K
Gross Margin57.6%60.7%60.3%23.0%50.3%
R&D Expenses$6M$6M$5M$0$0
SG&A Expenses$13M$20M$14M$11M$33K
Operating Expenses$19M$32M$25M$22M$321K
Operating Income-$12M-$19M-$16M-$18M-$228K
Operating Margin-113.7%-91.7%-120.8%-86.4%-123.1%
Interest Expense$0$2M$854K-$915K$0
Income Before Tax-$12M-$34M-$59M-$21M-$171K
Tax Expense-$109K-$12K-$716K$0-$18K
Net Income-$12M-$34M-$59M-$21M-$153K
Net Margin-112.7%-162.3%-429.6%-103.7%-82.7%
EPS (Diluted)$-40.71$-26.18$-20.02$-0.51$-0.00
EBITDA-$12M-$1M-$12M-$18M-$113K
Shares Outstanding3022691M3M32M899M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms